Literature DB >> 18780013

The management of pit viper envenomation of the hand.

Mehmet Bozkurt1, Yalcin Kulahci, Fatih Zor, Emin Kapi.   

Abstract

Snakebites are common among the rural population of developing countries. The severity of venomous snakebites depends on several factors, including the location of the bite, the amount of venom injected, and the effectiveness of the initial therapy. Snakebites frequently occur in the extremities with approximately two thirds of envenomations occurring in the upper extremities. In this study, we presented 12 cases of hand reconstruction after Vipera snakebites and discussed how to minimize functional loss and maximize hand rehabilitation. Twelve patients bitten by Vipera between 2001 and 2006 were included in this study. Groin flaps were performed in three cases, full-thickness grafts in two cases, thenar flaps in three cases, and cross finger flaps in three cases. With medical management, spontaneous healing occurred in one case. We prefer to use flaps on the volar site of the hand and, if the bone is not exposed, full-thickness grafts on the dorsal site of the hand. We also recommend starting rehabilitation of the hand early.

Entities:  

Year:  2008        PMID: 18780013      PMCID: PMC2584225          DOI: 10.1007/s11552-008-9114-2

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  20 in total

Review 1.  Venomous snakes of Saudi Arabia and the Middle East: a keynote for travellers.

Authors:  M Ismail; Z A Memish
Journal:  Int J Antimicrob Agents       Date:  2003-02       Impact factor: 5.283

2.  Bites by venomous snakes.

Authors:  E Van den Enden
Journal:  Acta Clin Belg       Date:  2003 Nov-Dec       Impact factor: 1.264

3.  Neutralization of kinin-releasing enzymes from viperid venoms by antivenom IgG fragments.

Authors:  A al-Joufi; G S Bailey; K Reddi; D C Smith
Journal:  Toxicon       Date:  1991       Impact factor: 3.033

4.  Biphasic rattlesnake venom-induced thrombocytopenia.

Authors:  Steven R Offerman; J David Barry; Aaron Schneir; Richard F Clark
Journal:  J Emerg Med       Date:  2003-04       Impact factor: 1.484

5.  Recurrent and persistent coagulopathy following pit viper envenomation.

Authors:  L V Boyer; S A Seifert; R F Clark; J T McNally; S R Williams; S P Nordt; F G Walter; R C Dart
Journal:  Arch Intern Med       Date:  1999-04-12

6.  Sensibility testing in peripheral-nerve compression syndromes. An experimental study in humans.

Authors:  R H Gelberman; R M Szabo; R V Williamson; M P Dimick
Journal:  J Bone Joint Surg Am       Date:  1983-06       Impact factor: 5.284

7.  Snake envenomation in a north Indian hospital.

Authors:  N Sharma; S Chauhan; S Faruqi; P Bhat; S Varma
Journal:  Emerg Med J       Date:  2005-02       Impact factor: 2.740

8.  Hemostatic disturbances observed in patients with snakebite in south China.

Authors:  Q B Li; Q S Yu; G W Huang; Y Tokeshi; M Nakamura; K Kinjoh; T Kosugi
Journal:  Toxicon       Date:  2000-10       Impact factor: 3.033

Review 9.  Treatment of snakebite poisoning.

Authors:  T A Smith; H L Figge
Journal:  Am J Hosp Pharm       Date:  1991-10

10.  [The management of snake envenomation: evaluation of twenty-one snake bite cases].

Authors:  Rüştü Köse
Journal:  Ulus Travma Acil Cerrahi Derg       Date:  2007-10
View more
  3 in total

1.  Bite injuries to the hand: microbiology, virology and management.

Authors:  M Malahias; D Jordan; O Hughes; Wasim S Khan; S Hindocha
Journal:  Open Orthop J       Date:  2014-06-27

Review 2.  Snake Bite Management: A Scoping Review of the Literature.

Authors:  Jeffrey J Russell; Anna Schoenbrunner; Jeffrey E Janis
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-04-29

3.  Comparison of Preclinical Properties of Several Available Antivenoms in the Search for Effective Treatment of Vipera ammodytes and Vipera berus Envenoming.

Authors:  Tihana Kurtović; Maja Lang Balija; Miran Brvar; Mojca Dobaja Borak; Sanja Mateljak Lukačević; Beata Halassy
Journal:  Toxins (Basel)       Date:  2021-03-13       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.